Límites al uso de marcas ajenas en el comercio paralelo de medicamentos: las recientes decisiones de los tribunales de marca de la unión europea de alicante

Spanish courts with jurisdiction over European Union trademarks have recently issued several rulings addressing the limits on the use of third-party trademarks in the context of parallel imports of medicinal productos. This article reviews the case law of the CJEU on the matter and analyzes how recent Spanish decisions have rigorously applied this jurisprudential framework, strengthening the protection of medicinal products trademark holders against conduct that exceeds the limits of lawful parallel trade.